$76.99
+0.02 (+0.03%)
Analyst Consensus
Hold
11
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
-89.6% upside
Low Target
$5.39
Average Target
$7.97
High Target
$9.61
Current Price
$76.99
Current
$76.99
$76.99
Target
$7.97
$7.97
$5.39
$7.97 avg
$9.61
Scenario Analysis
Bear Case
$5.39
-93.0%
Low target
Base Case
$7.97
-89.6%
Avg target
Bull Case
$9.61
+-87.5%
High target
Risk/Reward
0.9x
Unfavorable
Price in Context
52-Week High
$77.20
-0.3% from high
52-Week Low
$10.30
+647.5% from low
Target vs 52W High
$7.97
-89.7% vs high
Next Earnings Report
Nov 12, 2026
4d
until earnings
EPS Est: $-0.95
Earnings in 4 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 82% | $257.58 | -11.6% |
| AMGN | Hold | 42 | 43% | $190.87 | -58.5% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +117.3% |
| VRTX | Strong Buy | 39 | 82% | $438.34 | -19.9% |
| MRNA | Hold | 31 | 35% | $149.45 | -41.2% |
| REGN | Buy | 37 | 70% | $76.80 | -91.5% |
| NTRA | Strong Buy | 30 | 90% | $142.91 | -54.0% |
| RVMD | Strong Buy | 29 | 93% | $114.11 | -40.7% |